The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it hold, with a mean price target of $96.
Booz Allen Hamilton Holding Corporation
BAH · the NYSE · USD · Market cap $9.1B
FAIL · Does not pass the screenAt the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Booz Allen Hamilton Holding Corporation holds its Markdown at $75.68. The statistical read favours the buyers, held for 9 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 9 days |
| Price at the screen | $75.68 |
| Valuation | 11.88 trailing · 11.26 forward price to earnings |
| Values screen | FAIL |
| Beta | 0.37 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 43.92% | Below 33% | Interest-bearing debt is 43.9% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 9.36% | Below 33% | Cash held in interest-bearing accounts and securities is 9.4% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Conscience OverlayThe quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 5.6% margin of safety to the base estimate.
Third-party analyst targets: 13 covering, consensus Hold. The average target sits +6% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGovernment contractor looks cheap until the debt bites
Booz Allen helps agencies keep systems running, yet the same contracts have left the balance sheet carrying too much debt. That single ethical red flag ends any interest here, even though the forward multiple sits at 9.5 times and return on equity reaches 81 percent. Revenue is already falling 6 percent, so the headline numbers offer no cushion once leverage is taken into account.
The 9 percent gap between the current price and our fair value looks attractive on paper, and analysts still cluster around an 80 dollar target. Moderate competitive protection and an 8 percent profit margin cannot offset the structural problem flagged by the screen. We therefore pass without hesitation.
High return on equity often flatters firms that borrow heavily to buy back shares. When revenue is shrinking, that leverage becomes a genuine risk rather than a clever tactic. Analysis, not advice.
| Forward P/E | 11.3xreasonably valued |
| Trailing P/E | 11.9xreasonably valued |
| EPS, trailing | 6.37 |
| EPS, forward | 6.72 |
| Revenue growth | -4.2%revenue is shrinking |
| Profit margin | 7.0%thin but positive margins |
| Return on equity | 68.6%an exceptional return on shareholder capital |
| FCF yield | 9.46% |
| Dividend yield | 309.00% |
| Debt to equity | 3.46heavy leverage: higher risk if revenue softens |
| Current ratio | 1.60healthy short-term liquidity |
| Beta | 0.37barely tracks the market's swings |
| Short interest, float | 0.07% |
| 52-week range | 59.50 - 109.10 |
| Moat | MODERATE |
| Market cap | $9.1B |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBAH trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 18.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it hold, with a mean price target of $96.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (12 analysts) rates it hold, with a mean price target of $96.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | METZFIELD DENNIS | Officer | 350 | $27,506 | |
| 2025-12-30 | LABEN NANCY J | Officer | 5,829 | · | |
| 2025-12-30 | METZFIELD DENNIS | Officer | 1,175 | · | |
| 2025-10-30 | ROZANSKI HORACIO | Chief Executive Officer | 23,800 | $2,014,908 | |
| 2025-08-04 | ROSSOTTI CHARLES OSSOLA | Director | 3,097 | · | |
| 2025-08-04 | JOHNSON ARTHUR E | Director | 2,020 | · | |
| 2025-08-04 | FLOURNOY MICHELE ANGELIQUE | Director | 3,276 | · | |
| 2025-08-04 | DIAL DEBRA L | Director | 2,020 | · | |
| 2025-08-04 | READ RORY P | Director | 3,097 | · | |
| 2025-08-04 | JEWETT ELLEN | Director | 2,020 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $74.95 | +4.6% | · | $1,046 | +4.6% |
| 2 months | $78.17 | +0.3% | · | $1,003 | +0.3% |
| 3 months | $77.11 | +1.7% | · | $1,017 | +1.7% |
| 6 months | $93.67 | -16.3% | $0.59 | $843 | -15.7% |
| 1 year | $98.21 | -20.2% | $2.24 | $821 | -17.9% |
| 2 years | $145.97 | -46.3% | $4.32 | $567 | -43.3% |
| 3 years | $97.97 | -20.0% | $6.24 | $864 | -13.6% |
| 5 years | $80.35 | -2.4% | $9.54 | $1,094 | +9.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BAH does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.